All About Nerves
User instructions: Hover over the speaker's image to reveal his or her biography. If using a mobile device, tap the speaker's image to reveal his or her biography.
This presentation will provide a historical perspective on the evolution of peripheral nerve repair using allograft tissue and a summary of clinical applications. This will set up the second presentation, which will dive into peripheral nerve tissue banking.
Speakers: Ivan Ducic, MD and Erick DeVinney
Date: February 6, 2019
Time: 2:00 p.m. - 3:00 p.m. EST
Ivica (Ivan) Ducic joined AxoGen as Medical Director in January 2017. Dr. Ducic is a Board Certified Plastic Surgeon with additional training and expertise in peripheral nerve surgery. He received his medical degree in 1991 from the University of Zagreb School of Medicine (Croatia, Europe), and a Ph.D. degree in 1995 in Neuroscience. Upon completing plastic surgery training at Georgetown University Hospital in 2002, he entered a one-year peripheral nerve surgery fellowship. He then joined the full-time faculty practice at Georgetown University Hospital Department of Plastic Surgery in August 2003, where he served as the Professor of Plastic Surgery and Neurosurgery and he is the Founder/Director of their Peripheral Nerve Surgery Institute. Dr. Ducic established his own practice in 2014, the Washington Nerve Institute in McLean, VA, where he continues to practice today. Among his many accomplishments, Dr. Ducic is the past president of American Society for Peripheral Nerve. He has also served on many committees, served as journal editor for peripheral nerve focused research, published over 90 peer-reviewed papers, authored 15 book chapters, and has been a prolific educator both nationally and internationally on the diagnosis and treatment of peripheral nerve injury.
Mr. DeVinney joined AxoGen Corporation in April 2007. He has served as Vice President of Clinical and Translational Sciences for AxoGen, Inc. since January 2014. Prior to his current role, he served as Director of Clinical and Translational Sciences for AxoGen, Inc. from November 2011 to January 2014 and for AxoGen Corporation from April 2007 to January 2014. Erick has over fifteen years of experience in the successful planning and management of clinical trials. He has a diverse background including research at a large academic facility and management of clinical operations for a medical device and pharmaceutical company. Erick has been involved in clinical research at Medical College of Virginia Hospitals, National Clinical Research, PRA International, and Angiotech. He has been involved in the successful submission of eight IDE or NDA applications as well as numerous 510(k)s. He has a B.S. in Chemistry from Virginia Commonwealth University.
This presentation will provide focus on the critical areas associated with the recovery of peripheral nerve tissue and processing of peripheral nerve tissue. The presentation will discuss recovery techniques and provide processing results (preservation of peripheral nerve tissue and decellularization of the tissue).
Speakers: Mark Friedman, PhD, CTBS and Jan Hendrix, CTBS
Date: February 20, 2019
Time: 2:00 p.m. - 3:00 p.m. EST
Dr. Friedman joined AxoGen in September 2006. He has served as Vice President of Regulatory Affairs and Quality Assurance for AxoGen, Inc. since November 2011, and AxoGen Corporation since June 2011. Prior to his current role, he served as Director of Quality Assurance and Regulatory Affairs from September 2006 to June 2011 for AxoGen Corporation. Prior to joining AxoGen, Mark held several regulatory and quality leadership positions at Enable Medical Corporation, a medical device company, including Director of Quality Assurance from 1997 to 1998, and Vice President of Quality and Regulatory from 1998 to 2001 and from 2004 to 2005. Mark also worked for AtriCure, Inc., a company that develops, manufactures and sells surgical ablation systems to treat atrial fibrillation, as Vice President of Quality and Regulatory from 2001 to 2004 and as Vice President of Operations in 2004. Mark has over 30 years of experience in developing and directing regulatory strategy and quality systems for medical products, including 15 years with startup medical product firms. Mark has a Ph.D. in Chemistry, specializing in protein biochemistry, from the University of Cincinnati.
Ms. Hendrix joined the AxoGen team in March 2018. Jan came to AxoGen after serving as the Director of Tissue Services at LifeCenter Northwest in Seattle, WA for 10 years. Jan was instrumental in starting the tissue recovery program there in 2008. Prior to that Jan held many positions at Northwest Tissue Center, the first full service tissue bank to serve the Pacific Northwest. Jan moved from Denver to Seattle in 1988 to assist in the launch of this new program which successfully served the Pacific Northwest for 20 years.